Skip to main content
Caplight Logo









Advanced NanoTherapies

Advanced NanoTherapies

Private
Santa Clara, CaliforniaHealthcare & Life Scienceshttps://advancednanotherapies.com/

Last Round

Series B

Jun 2, 2026

Total Funding Raised

$47.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Advanced NanoTherapies is a clinical-stage medical technology company developing a nanoparticle drug delivery platform for catheter-based interventions to treat coronary and peripheral artery disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

drug-coated balloonDCBnanoparticle drug deliveryrestenosis preventiondual-drug therapycoronary artery diseaseperipheral artery diseasedrug eluting balloonmedical devicenanomedicinevascular treatmentsinterventional cardiologyimplant-free treatmentsustained drug releasebiodegradable nanoparticlessmall vessel disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Advanced NanoTherapies Comparables

Compare Advanced NanoTherapies with similar companies based on industry and business-model similarity.

Advanced NanoTherapies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Encompass Vascular, Inc.
84%
Concept Medical Inc.
81%
Orchestra BioMed Holdings, Inc.
79%

Advanced NanoTherapies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 2, 2026
Series A ExtensionAug 22, 2023
Series AJun 28, 2022
SeedOct 13, 2020

Key People

Founding team and executive leadership

Marwan Berrada-Sounni

President, CEO, And Co-founder

Founding Team

Advanced NanoTherapies Investors

Notable investors and investment history

Advanced NanoTherapies investors
InvestorRounds
ForMED VenturesSeed
S3 VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Grew 31% QoQ, from 16 to 21 employees.

  • Jul 26, 2026

    Monthly visitors increased 318% MoM.

Advanced NanoTherapies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Advanced NanoTherapies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Advanced NanoTherapies's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range21
Year Founded2018
Last FundingJun 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?